Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 34 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted
  2. US 7976853

    Process for producing coated preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted
  3. US 7973163

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted
  4. US 7960416

    Stable emulsion composition

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  5. US 7960369

    Receptor function regulator

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  6. US 7960384

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  7. US 7960348

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  8. US 7951548

    IL-13 production inhibitor

    Takeda Pharmaceutical Company Limited · Granted May 31, 2011 · Expires May 26, 2031

    granted
  9. US 7943137

    FPRL1 ligands and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted
  10. US 7943770

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted
  11. US 7943659

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted
  12. US 7943626

    Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted
  13. US 7943580

    Polypeptide and the use thereof

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted
  14. US 7932289

    Remedy for diabetes

    Takeda Pharmaceutical Company Limited · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted
  15. US 7927821

    Methods of screening for compounds which bind G protein-coupled receptors

    Takeda Pharmaceutical Company Limited · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted
  16. US 7928105

    Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones

    Takeda Pharmaceutical Company Limited · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted
  17. US 7919260

    Screening methods using GPR52

    Takeda Pharmaceutical Company Limited · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted
  18. US 7915267

    Heterocyclic amide compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted
  19. US 7906523

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  20. US 7897607

    Cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted
  21. US 7892755

    Screening method

    Takeda Pharmaceutical Company Limited · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted
  22. US 7879564

    Use of the receptor GPR86

    Takeda Pharmaceutical Company Limited · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted
  23. US 7875292

    Orally disintegrable tablets

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted
  24. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted